Stock Events

Stock Events

HLS Therapeutics (74D.F) Q2 2024 Earnings

9MayConfirmed

Q2 2024

-0.18

-0.17

-0.16

-0.15

Details

Expected EPS

-0.14714664000000002

Actual EPS

-0.17616800000000002

Surprise EPS

-0.03

Surprise Percent

+19.72%

Description

HLS Therapeutics (74D.F) has reported earnings of -0.17616800000000002 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.